Search Results

FDA

Avioq Announces FDA Approval of VioOne™ HIV Profile™ Supplemental Assay

Avioq, Inc. announces it has received approval from the U.S. Food and Drug Administration (FDA) for their Vio One™ HIV Profile™ Supplemental Assay. The HIV Profile™ assay is an enzyme-linked immunosorbent assay (ELISA) for confirmation and differentiation of individual antibodies directed to various gene products of HIV-1 (Group

October 22, 2020

·

1 min read

Bio NC

Avioq Expands FDA And CE-IVD Claims For Testing Organ And Tissue Donors With The Avioq HTLV-I/II Microelisa System

April 27, 2015

·

1 min read

Deals

Avioq Announces the Completion Of Its Acquisition By Oriental Ocean Sci-tech Co., Ltd.

April 19, 2016

·

1 min read

FDA

Avioq Obtains Health Canada Approval For Screening Of Cadaveric Organ And Tissue Donors With The Avioq HTLV-I/II Microelisa System, Expands Already Approved Health Canada And CE-IVD Claims

January 28, 2016

·

1 min read

Bio NC

Cellex, Part Of The Avioq Family Of Companies, Receives NIH Grant To Develop Rapid Test For Detection Of Carbapenemase Producing Organisms (CPOs)

July 12, 2016

·

2 min read

FDA

Avioq Announces Health Canada Approval and Canadian Launch of HTLV-I/II Test

August 13, 2013

·

1 min read

FDA

Avioq Announces CE Mark and European Launch of HTLV-I/II Test

April 11, 2013

·

2 min read

FDA

Avioq Receives FDA Approval for HTLV-I/II Microelisa System

March 28, 2012

·

3 min read

FDA

Avioq Receives FDA Approval for Anti-HIV-1 Microelisa System for Detection of Antibodies to HIV-1 in Serum, Plasma, Dried Blood Spots, or Oral Fluid Specimens Obtained with the OraSure(R) HIV-1 Oral Specimen Collection Device

December 1, 2009

·

2 min read

Serological Transplant Diagnostics Market to Register a Steady Growth of 2.5% by 2031: Fact MR

Fact.MR – A Market Research and Competitive Intelligence Provider: As per Fact.MR, the global serological transplant diagnostics market is projected to expand at a CAGR of 2.5% during the forecast period, 2021-2031 on the back of rapid advancements in the medical and diagnostic sectors.

January 5, 2022

·

7 min read